PointState Capital’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-30,020
Closed -$18.2M 178
2021
Q3
$18.2M Buy
30,020
+7,020
+31% +$4.36M 0.43% 61
2021
Q2
$12.8M Buy
+23,000
New +$11.7M 0.3% 71
2021
Q1
Sell
-35,733
Closed -$17.3M 168
2020
Q4
$17.3M Buy
35,733
+19,313
+118% +$10.4M 0.43% 62
2020
Q3
$9.19M Sell
16,420
-25,927
-61% -$15.7M 0.31% 59
2020
Q2
$26.4M Buy
42,347
+32,804
+344% +$18.6M 1.01% 29
2020
Q1
$4.66M Sell
9,543
-125,025
-93% -$51.6M 0.31% 38
2019
Q4
$50.5M Buy
134,568
+120,368
+848% +$40.5M 1.38% 33
2019
Q3
$3.94M Buy
+14,200
New +$4.2M 0.16% 72
2017
Q3
Sell
-159,220
Closed -$78.2M 175
2017
Q2
$78.2M Buy
+159,220
New +$69.7M 0.92% 38

Other funds holding REGN